![]() | Only 14 pages are availabe for public view |
Abstract SUMMARY AND CONCLUSIONS RARC is an evolving technique in the developed countries and has become a common practice in many high-volume centers. The data in the literature has documented a lot of merits in the perioperative outcomes as decreased blood loss and lower transfusion rates. Moreover, the early oncologic outcomes are non-inferior to the open surgery. However, the main cons of robotic surgeries are its relatively high cost and steep learning curve. Therefore, the aim of this study was to compare the perioperative and early oncologic outcomes of RARC with ORC, the gold standard operation. This study was a prospective non-randomized comparative study that was conducted on 100 patients with bladder cancer who were scheduled for RC in two tertiary centers. Forty-seven participants undergoing ORC were recruited from Tanta University Hospital (group I) while 53 patients undergoing RARC were included from Guy‘s hospital in London (group II). Data was statistically analyzed and revealed the following results: Regarding the patients‘ demographic data, the patients in group II were older with more complex comorbidities than their comparators in group I. Visible hematuria was the most common complaint in both groups (74% in group I and 73% in group II). Most of the tumors in both groups were urothelial with 66 % in group I versus 64% in group II. The presence of carcinoma in situ in the TURBT histology was significantly more in group I (p=0.029). The total operative time was slightly lower in group I; however, without any significant statistical difference (p=0.319). |